Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your experience. Save up to 40% More details

Tilray's Good News Is Simply Not Good Enough

By (Brenda O'Farrell/ MarketsOct 12, 2021 11:17
Tilray's Good News Is Simply Not Good Enough
By (Brenda O'Farrell/   |  Oct 12, 2021 11:17
Saved. See Saved Items.
This article has already been saved in your Saved Items

Shares of Tilray (NASDAQ:TLRY) dropped almost 5% last Friday to close the week at $10.49, which is a far distance from its most recent high in February of just over $29. They slipped some more yesterday, closing at $10.16

TLRY Weekly Chart
TLRY Weekly Chart

The latest downward pressure comes in the wake of the cannabis producer’s quarterly earnings report unveiled last Thursday that saw its sales in the three-month period that ended Aug. 31 jump a respectable 38%.

Despite the positive numbers reported, the pressure on the company’s share price was a reflection of the results not meeting expectations. Call it a case of good, not being good enough.

Tilray posted first quarter revenues of $168 million, a jump of 43% from the same period in the previous year. This increase, in large part, was driven by its three main sectors—cannabis sales of $70 million, net alcoholic beverage revenue of $15 million, and what the company terms its wellness revenue of $15 million, which stems from its Manitoba Harvest sales.

But that was not the only good news. According to its financial report, Tilray maintained its ranking as having the biggest slice of the Canadian market, which includes both medical and recreational offerings.

It is also the top company in the German medical cannabis market.

But the bottom line was a net loss for the quarter of $34.6 million, a much larger deficit compared with the net loss of $21.7 million in the same period the year before. Adjusted EBITDA was pegged at $12.7 million for the quarter.

Given the company’s recent merger with Aphria (NASDAQ:APHA), cost savings synergies are having an impact. The actual cost savings for the quarter were listed at $20 million, and they are reportedly on track to hit $80 million overall, according to the statement released last week.

Following the release of the earnings report, Tilray CEO Irwin Simon gave an interview with BNN Bloomberg. His comments about the layout of the cannabis sector attracted attention. They provided a succinct look at what is perhaps one of the biggest challenges facing the big players in the cannabis market.

Although Tilray has confirmed its spot as the leading player in the Canadian cannabis market, and provided the figures to support the claim, Simon said the company’s position is being challenged by what he described as “ankle biters,” small producers that are nibbling away at its market share.

As BNN Bloomberg reported:

"If you look at us, Hexo (NASDAQ:HEXO), Canopy Growth (NASDAQ:CGC) and Aurora (NASDAQ:ACB), all together we have 50 per cent share [of the market]," Simon said. "Underneath that, you have 450 licensed producers that are all ankle biters that are taking a little bit of share away. That's what we have to contend with and make sure we're selling our products and educating budtenders."

The remarks probably did not make him any friends, but they reflect a situation on the ground that will continue to be a huge challenge—and that is brand recognition and marketing. With so many marketing products, it is difficult for consumers to know which way to turn and allow any producer to gain real traction.

Tilray's Good News Is Simply Not Good Enough

Related Articles

Tilray's Good News Is Simply Not Good Enough

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email